Moreover, these results demonstrate that LAT1 may be a predictor of clinical prognosis in breast cancer patients as well as a predictive factor of the therapeutic efficacy of preoperative and postoperative chemotherapy. This evidence concerns the gene SLC7A5 and breast carcinoma.